Moderated Poster Sessions

Chairs: Dr Michael Clarkson, Dr Mitchell Lawrence

Back to list

Overview

Contrasting exercise modes enhance muscle strength and physical function in prostate cancer survivors undertaking androgen deprivation therapy: A 12-month randomized controlled trial.

Time:
3:30 PM - 3:38 PM
Speakers:

Miss Rebekah Wilson

PDK1 dependent aerobic glycolysis and tumorigenesis in prostate cancer is regulated by miRNAs in an allele dependent manner

Time:
3:39 PM - 3:47 PM
Speakers:

Miss Sugarniya Subramaniam

Molecular mechanisms of metformin in prostate cancer – Mitochondrial toxicity and apoptosis

Time:
3:48 PM - 3:56 PM
Speakers:

Dr Handoo Rhee

Phosphorylation of the androgen receptor and its splicing variants in prostate cancer

Time:
3:57 PM - 4:05 PM
Speakers:

Ms BoSeul Song

The potential for androgen influenced disruption of the mismatch repair gene Msh2 in Prostate Cancer

Time:
4:06 PM - 4:14 PM
Speakers:

Mr Patrick McCoy

SVclone: inference of cancer cell fraction using structural variation

Time:
4:15 PM - 4:23 PM
Speakers:

Mr Marek Cmero

A review of the differences in genetic landscapes between ductal and acinar adenocarcinoma of the prostate

Time:
4:24 PM - 4:32 PM
Speakers:

Dr Ken Chow

Autonomic nerves and perineural invasion in prostate cancer

Time:
4:33 PM - 4:41 PM
Speakers:

Dr Fairleigh Reeves

Periprostatic fat holds a field-effect transcriptional signature of cancer grade

Time:
4:42 PM - 4:50 PM
Speakers:

Mr Ryan Stuchbery

The role of FGF7 in castration resistant prostate cancer.

Time:
4:51 PM - 4:59 PM
Speakers:

Miss Natalie Kurganovs

A computational tool for deconvolving cell type specific transcriptomes from tumour microenvironment mixtures

Time:
5:00 PM - 5:08 PM
Speakers:

Dr Stefano Mangiola